From first‐trimester screening to risk stratification of evolving pre‐eclampsia in second and third trimesters of pregnancy: comprehensive approach

Saved in:
Bibliographic Details
Published inUltrasound in obstetrics & gynecology Vol. 55; no. 1; pp. 5 - 12
Main Authors Poon, L. C., Galindo, A., Surbek, D., Chantraine, F., Stepan, H., Hyett, J., Tan, K. H., Verlohren, S.
Format Journal Article Web Resource
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.01.2020
Wiley Subscription Services, Inc
John Wiley and Sons Ltd
Subjects
Eclampsia
Female
General Medicine
Health risk assessment
Human health sciences
Humans
Médecine de la reproduction (Gynécologie, andrologie, obstétrique)
Obstetrics and Gynecology
Pre-Eclampsia
Pre-Eclampsia/diagnosis
Predictive Value of Tests
Preeclampsia
Pregnancy
Pregnancy complications
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Prenatal Diagnosis
Radiological and Ultrasound Technology
Radiology, Nuclear Medicine and Imaging
Reproductive Medicine
Reproductive medicine (gynecology, andrology, obstetrics)
Risk Assessment
Sciences de la santé humaine
Ultrasonic imaging
Ultrasonography, Prenatal
Online AccessGet full text
ISSN0960-7692
1469-0705
1469-0705
DOI10.1002/uog.21869

Cover

Author Hyett, J.
Tan, K. H.
Surbek, D.
Stepan, H.
Poon, L. C.
Galindo, A.
Verlohren, S.
Chantraine, F.
Author_xml – sequence: 1
  givenname: L. C.
  orcidid: 0000-0002-3944-4130
  surname: Poon
  fullname: Poon, L. C.
  organization: Prince of Wales Hospital, The Chinese University of Hong Kong
– sequence: 2
  givenname: A.
  surname: Galindo
  fullname: Galindo, A.
  organization: University Hospital 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid
– sequence: 3
  givenname: D.
  surname: Surbek
  fullname: Surbek, D.
  organization: Inselspital Bern University Hospital, University of Bern
– sequence: 4
  givenname: F.
  surname: Chantraine
  fullname: Chantraine, F.
  organization: CHU Liege
– sequence: 5
  givenname: H.
  surname: Stepan
  fullname: Stepan, H.
  organization: University Hospital Leipzig
– sequence: 6
  givenname: J.
  surname: Hyett
  fullname: Hyett, J.
  organization: Royal Prince Alfred Hospital
– sequence: 7
  givenname: K. H.
  surname: Tan
  fullname: Tan, K. H.
  organization: KK Women's and Children's Hospital
– sequence: 8
  givenname: S.
  orcidid: 0000-0003-3507-8636
  surname: Verlohren
  fullname: Verlohren, S.
  email: stefan.verlohren@charite.de
  organization: Charité – Universitätsmedizin Berlin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31503374$$D View this record in MEDLINE/PubMed
BookMark eNp1kstuEzEUhi1URNPCghdAltjAIq0vE3vMDlW0IFXqhq4t5-TMxGXGHuyZoOx4BHa8H0-C0ySbChY-Ppa-_5fP5YychBiQkNecXXDGxOUU2wvBa2WekRmvlJkzzRYnZMaMYnOtjDglZzk_MMZUJdULcir5gkmpqxn5fZ1iTxuf8vjn568x-R7ziIlmSIjBh5aOkSafv9E8Jjf6xkOJMdDYUNzEbrNDhoRFjNC5fsjeUR9oRohhRV0549qnEo_WeSctija4ANsPFGJfXmsM2W-QumFI0cH6JXneuC7jq8N9Tu6vP329-jy_vbv5cvXxdg6VFGbumNOM104bU-sGhQRQBrFaiUaA4sZA4xhUJZFVLRBqrrReLTVIAUY1Tp4TufftPLZoY1p6uxE2Or_Pp661DuwSrRCqtpILLquierdXlc9-n0pZtvcZsOtcwDjlwtY146XDi4K-fYI-xCmFUpMVUnLNtOI76s2BmpY9ruxQuuXS1h4HVYDLPQAp5pywseDHx0mUsfjOcmZ3q2DLKtjHVSiK908UR9N_sQf3H77D7f9Be393s1f8Be1DxzY
CitedBy_id crossref_primary_10_1002_jcu_23904
crossref_primary_10_1038_s41440_023_01509_2
crossref_primary_10_1161_HYPERTENSIONAHA_120_15146
crossref_primary_10_1016_j_ajog_2020_09_046
crossref_primary_10_3390_medicina59050891
crossref_primary_10_1210_clinem_dgaa403
crossref_primary_10_1002_kjm2_12907
crossref_primary_10_1002_uog_26032
crossref_primary_10_30841_2708_8731_7_2022_272468
crossref_primary_10_1016_j_ajogmf_2020_100100
crossref_primary_10_1080_10641955_2020_1750627
crossref_primary_10_1007_s12011_022_03178_7
crossref_primary_10_1016_j_bpobgyn_2023_102436
crossref_primary_10_3389_fmed_2023_1191163
crossref_primary_10_1016_j_preghy_2021_12_003
crossref_primary_10_1016_j_xagr_2023_100193
crossref_primary_10_1080_10641955_2021_1921793
crossref_primary_10_1097_FM9_0000000000000101
crossref_primary_10_1016_j_ajog_2023_03_032
crossref_primary_10_3390_jcm13061774
crossref_primary_10_1016_j_vhri_2022_09_003
crossref_primary_10_1155_2023_3668689
crossref_primary_10_23736_S2724_606X_22_05083_7
crossref_primary_10_1007_s00129_024_05233_x
crossref_primary_10_1186_s12884_021_04144_2
crossref_primary_10_1016_j_preghy_2021_05_021
Cites_doi 10.1056/NEJMoa055352
10.1136/bmj.332.7539.463
10.1002/uog.19112
10.1016/j.ajog.2008.06.069
10.1002/uog.19099
10.1016/j.ajog.2017.11.561
10.1097/AOG.0000000000001525
10.1002/uog.19019
10.1155/2018/6268276
10.1186/1471-2393-14-324
10.1097/AOG.0b013e3181e9322a
10.1002/uog.19076
10.1056/NEJMoa1414838
10.1016/j.ajog.2016.10.016
10.1161/HYPERTENSIONAHA.113.01787
10.1002/uog.18816
10.18203/2320-1770.ijrcog20182333
10.1016/j.ajog.2017.08.110
10.1056/NEJMoa031884
10.1016/j.ajog.2015.08.034
10.3390/ijms160819009
10.1161/HYPERTENSIONAHA.116.08620
10.1111/1471-0528.13334
10.1016/j.preghy.2018.06.017
10.1111/1471-0528.15042
10.1002/uog.17307
10.1097/AOG.0b013e3181a45b25
10.1016/j.preghy.2014.02.001
10.1002/pd.4519
10.1161/HYPERTENSIONAHA.117.10182
10.1111/1471-0528.12629
10.1016/j.ajog.2015.02.018
10.1007/s40265-017-0823-0
10.1002/pd.2685
10.1002/uog.19039
10.1016/j.ajog.2016.09.076
10.1002/uog.19111
10.1056/NEJMoa1704559
10.1016/j.ajog.2018.11.1087
10.1016/j.ajog.2011.07.037
10.1186/1471-2393-13-110
10.1161/HYPERTENSIONAHA.108.127977
10.1053/j.semperi.2009.02.010
10.1016/j.ajog.2009.07.025
10.1038/hr.2010.15
10.1067/mob.2003.111
10.1016/j.ajog.2004.11.038
10.1186/s12913-018-3406-1
10.1161/HYPERTENSIONAHA.117.10803
10.1002/uog.15997
10.1002/uog.19178
10.1016/S0140-6736(10)60279-6
10.1016/j.ajog.2017.07.038
10.3390/ijms160817952
10.1002/uog.15982
10.1161/HYPERTENSIONAHA.119.12760
10.1016/j.ajog.2015.11.016
10.1016/j.clinbiochem.2010.02.010
ContentType Journal Article
Web Resource
Copyright 2019 The Authors. published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
2019. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2019 The Authors. published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
– notice: 2019. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
7QO
8FD
FR3
K9.
P64
7X8
Q33
DOI 10.1002/uog.21869
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Université de Liège - Open Repository and Bibliography (ORBI)
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1469-0705
EndPage 12
ExternalDocumentID oai_orbi_ulg_ac_be_2268_312134
31503374
10_1002_uog_21869
UOG21869
Genre commentary
Journal Article
GrantInformation_xml – fundername: Roche Diagnostics
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OC
24P
29Q
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
ESX
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HF~
HGLYW
HHY
HHZ
HZ~
IHE
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XV2
YFH
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
NPM
7QO
8FD
FR3
K9.
P64
7X8
Q33
ID FETCH-LOGICAL-c4329-a0a7018a79987fe23cc69ee4d2f2c6199cfa0c41993482ec81677db7c32c96fa3
IEDL.DBID DR2
ISSN 0960-7692
1469-0705
IngestDate Fri Jul 18 15:34:48 EDT 2025
Fri Jul 11 05:45:17 EDT 2025
Sat Jul 12 03:14:14 EDT 2025
Wed Feb 19 02:31:19 EST 2025
Thu Jul 03 08:45:58 EDT 2025
Thu Apr 24 22:58:49 EDT 2025
Wed Jan 22 16:35:51 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Attribution
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4329-a0a7018a79987fe23cc69ee4d2f2c6199cfa0c41993482ec81677db7c32c96fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
scopus-id:2-s2.0-85077199329
ORCID 0000-0002-3944-4130
0000-0003-3507-8636
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fuog.21869
PMID 31503374
PQID 2331707615
PQPubID 1006490
PageCount 8
ParticipantIDs liege_orbi_v2_oai_orbi_ulg_ac_be_2268_312134
proquest_miscellaneous_2288013375
proquest_journals_2331707615
pubmed_primary_31503374
crossref_citationtrail_10_1002_uog_21869
crossref_primary_10_1002_uog_21869
wiley_primary_10_1002_uog_21869_UOG21869
PublicationCentury 2000
PublicationDate January 2020
2020-01-00
2020-Jan
20200101
2020-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: January 2020
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: London
PublicationTitle Ultrasound in obstetrics & gynecology
PublicationTitleAlternate Ultrasound Obstet Gynecol
PublicationYear 2020
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
John Wiley and Sons Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Ltd
References 2015; 35
2019; 53
2017; 49
2018; 125
2013; 122
2009; 113
2014; 63
2014; 210
2006; 332
2012; 206
2018; 7
2014; 4
2009; 53
2013; 13
2015; 213
2018; 218
2010; 116
2017; 77
2014; 14
2012; 29
2018; 72
2018; 71
2014; 121
2008; 199
2016; 48
2010; 33
2005; 193
2015; 16
2019; 74
2017; 69
2015; 122
2010; 202
2011; 31
2016; 128
2017; 377
2011; 7
2017; 216
2006; 355
2019; 220
2017; 217
2009; 33
2017; 50
2010; 43
2018; 18
2018; 2018
2004; 350
2010; 376
2016; 374
2018; 52
2018; 51
2016; 214
2003; 188
2018; 13
e_1_2_3_50_1
Uzan J (e_1_2_3_4_1) 2011; 7
e_1_2_3_2_1
e_1_2_3_6_1
e_1_2_3_16_1
e_1_2_3_39_1
e_1_2_3_18_1
Wright D (e_1_2_3_47_1) 2018; 218
e_1_2_3_12_1
e_1_2_3_35_1
e_1_2_3_58_1
e_1_2_3_56_1
e_1_2_3_8_1
e_1_2_3_14_1
e_1_2_3_37_1
e_1_2_3_31_1
e_1_2_3_52_1
e_1_2_3_10_1
e_1_2_3_33_1
e_1_2_3_54_1
e_1_2_3_62_1
e_1_2_3_60_1
e_1_2_3_28_1
e_1_2_3_49_1
e_1_2_3_24_1
e_1_2_3_45_1
American College of Obstetricians and Gynecologists. Hypertension in pregnancy (e_1_2_3_5_1) 2013; 122
e_1_2_3_26_1
e_1_2_3_20_1
Roberge S (e_1_2_3_23_1) 2012; 29
e_1_2_3_41_1
e_1_2_3_66_1
e_1_2_3_22_1
e_1_2_3_43_1
e_1_2_3_64_1
e_1_2_3_51_1
e_1_2_3_17_1
e_1_2_3_38_1
e_1_2_3_3_1
e_1_2_3_19_1
Nelson DB (e_1_2_3_11_1) 2014; 210
e_1_2_3_57_1
e_1_2_3_9_1
e_1_2_3_13_1
e_1_2_3_34_1
e_1_2_3_59_1
e_1_2_3_7_1
e_1_2_3_15_1
e_1_2_3_36_1
e_1_2_3_30_1
e_1_2_3_53_1
e_1_2_3_55_1
e_1_2_3_32_1
e_1_2_3_61_1
e_1_2_3_40_1
e_1_2_3_27_1
e_1_2_3_29_1
e_1_2_3_46_1
e_1_2_3_25_1
e_1_2_3_48_1
e_1_2_3_42_1
e_1_2_3_65_1
e_1_2_3_21_1
e_1_2_3_44_1
e_1_2_3_63_1
References_xml – volume: 4
  start-page: 97
  year: 2014
  end-page: 104
  article-title: The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP
  publication-title: Pregnancy Hypertens
– volume: 50
  start-page: 492
  year: 2017
  end-page: 495
  article-title: ASPRE trial: performance of screening for preterm pre‐eclampsia
  publication-title: Ultrasound Obstet Gynecol
– volume: 74
  start-page: 164
  year: 2019
  end-page: 172
  article-title: Short‐term prediction of adverse outcomes using the sFlt‐1 (soluble fms‐like tyrosine kinase 1)/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia
  publication-title: Hypertension
– volume: 49
  start-page: 201
  year: 2017
  end-page: 208
  article-title: Comparison of screening for pre‐eclampsia at 31–34 weeks' gestation by sFlt‐1/PlGF ratio and a method combining maternal factors with sFlt‐1 and PlGF
  publication-title: Ultrasound Obstet Gynecol
– volume: 69
  start-page: 731
  year: 2017
  end-page: 738
  article-title: Prediction of preeclampsia using the soluble fms‐like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women
  publication-title: Hypertension
– volume: 53
  start-page: 812
  year: 2009
  end-page: 818
  article-title: First‐trimester prediction of hypertensive disorders in pregnancy
  publication-title: Hypertension
– volume: 14
  year: 2014
  article-title: Multicenter prospective clinical study to evaluate the prediction of short‐term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol
  publication-title: BMC Pregnancy Childbirth
– volume: 51
  start-page: 743
  year: 2018
  end-page: 750
  article-title: Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
  publication-title: Ultrasound Obstet Gynecol
– volume: 377
  start-page: 613
  year: 2017
  end-page: 622
  article-title: Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
  publication-title: N Engl J Med
– volume: 16
  start-page: 19009
  year: 2015
  end-page: 19026
  article-title: Angiogenesis‐related biomarkers (sFlt‐1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration
  publication-title: Int J Mol Sci
– volume: 216
  start-page: 110
  year: 2017
  end-page: 120.e6
  article-title: The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis
  publication-title: Am J Obstet Gynecol
– volume: 122
  start-page: 1122
  year: 2013
  end-page: 1131
  article-title: Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy
  publication-title: Obstet Gynecol
– volume: 53
  start-page: 239
  year: 2019
  end-page: 244
  article-title: Cost‐effectiveness of first‐trimester screening with early preventative use of aspirin in women at high risk of early‐onset pre‐eclampsia
  publication-title: Ultrasound Obstet Gynecol
– volume: 16
  start-page: 17952
  year: 2015
  end-page: 17974
  article-title: Combined screening for early detection of pre‐eclampsia
  publication-title: Int J Mol Sci
– volume: 216
  start-page: 121
  year: 2017
  end-page: 128.e2
  article-title: Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta‐analysis
  publication-title: Am J Obstet Gynecol
– volume: 7
  start-page: 2266
  year: 2018
  end-page: 2269
  article-title: Early onset and late onset preeclampsia‐maternal and perinatal outcomes in a rural teritiary health center
  publication-title: Int J Reprod Contracept Obstet Gynecol
– volume: 51
  start-page: 738
  year: 2018
  end-page: 742
  article-title: ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
  publication-title: Ultrasound Obstet Gynecol
– volume: 52
  start-page: 186
  year: 2018
  end-page: 195
  article-title: Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
  publication-title: Ultrasound Obstet Gynecol
– volume: 72
  start-page: 24
  year: 2018
  end-page: 43
  article-title: Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice
  publication-title: Hypertension
– volume: 63
  start-page: 346
  year: 2014
  end-page: 352
  article-title: New gestational phase‐specific cutoff values for the use of the soluble fms‐like tyrosine kinase‐1/placental growth factor ratio as a diagnostic test for preeclampsia
  publication-title: Hypertension
– volume: 52
  start-page: 365
  year: 2018
  end-page: 372
  article-title: Management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
  publication-title: Ultrasound Obstet Gynecol
– volume: 214
  start-page: 619.e1
  year: 2016
  end-page: 17
  article-title: Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19‐24 weeks' gestation
  publication-title: Am J Obstet Gynecol
– volume: 7
  start-page: 467
  year: 2011
  end-page: 474
  article-title: Pre‐eclampsia: pathophysiology, diagnosis, and management
  publication-title: Vasc Health Risk Manag
– volume: 220
  start-page: 199.e1
  year: 2019
  end-page: 13
  article-title: Predictive performance of the competing risk model in screening for preeclampsia
  publication-title: Am J Obstet Gynecol
– volume: 121
  start-page: 14
  issue: Suppl 1
  year: 2014
  end-page: 24
  article-title: Pre‐eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health
  publication-title: BJOG
– volume: 214
  start-page: 103.e1
  year: 2016
  end-page: 12
  article-title: Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11‐13 weeks gestation
  publication-title: Am J Obstet Gynecol
– volume: 35
  start-page: 183
  year: 2015
  end-page: 191
  article-title: First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors
  publication-title: Prenat Diagn
– volume: 125
  start-page: 1389
  year: 2018
  end-page: 1395
  article-title: Angiogenic factors: potential to change clinical practice in pre‐eclampsia?
  publication-title: BJOG
– volume: 122
  start-page: 904
  year: 2015
  end-page: 914
  article-title: Quality of first trimester risk prediction models for pre‐eclampsia: a systematic review
  publication-title: BJOG
– volume: 213
  start-page: 62.e1
  year: 2015
  end-page: 10
  article-title: Competing risks model in screening for preeclampsia by maternal characteristics and medical history
  publication-title: Am J Obstet Gynecol
– volume: 52
  start-page: 501
  year: 2018
  end-page: 506
  article-title: Screening for pre‐eclampsia at 35–37 weeks' gestation
  publication-title: Ultrasound Obstet Gynecol
– volume: 202
  start-page: 40.e1
  year: 2010
  end-page: 7
  article-title: Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study
  publication-title: Am J Obstet Gynecol
– volume: 206
  start-page: 58.e1
  year: 2012
  end-page: 8
  article-title: The sFlt‐1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
  publication-title: Am J Obstet Gynecol
– volume: 29
  start-page: 551
  year: 2012
  end-page: 556
  article-title: Early administration of low‐dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta‐analysis
  publication-title: Am J Perinatol
– volume: 18
  year: 2018
  article-title: Economic assessment of the use of the sFlt‐1/PlGF ratio test to predict preeclampsia in Germany
  publication-title: BMC Health Serv Res
– volume: 350
  start-page: 672
  year: 2004
  end-page: 683
  article-title: Circulating angiogenic factors and the risk of preeclampsia
  publication-title: N Engl J Med
– volume: 193
  start-page: 185
  year: 2005
  end-page: 191
  article-title: Maternal serum soluble fms‐like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
  publication-title: Am J Obstet Gynecol
– volume: 13
  start-page: 279
  year: 2018
  end-page: 285
  article-title: Clinical implementation of the sFlt‐1/PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study
  publication-title: Pregnancy Hypertens
– volume: 199
  start-page: 266.e1
  year: 2008
  end-page: 6
  article-title: First‐trimester serum levels of soluble endoglin and soluble fms‐like tyrosine kinase‐1 as first‐trimester markers for late‐onset preeclampsia
  publication-title: Am J Obstet Gynecol
– volume: 374
  start-page: 13
  year: 2016
  end-page: 22
  article-title: Predictive value of the sFlt‐1:PlGF ratio in women with suspected preeclampsia
  publication-title: N Engl J Med
– volume: 188
  start-page: 177
  year: 2003
  end-page: 182
  article-title: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies
  publication-title: Am J Obstet Gynecol
– volume: 77
  start-page: 1819
  year: 2017
  end-page: 1831
  article-title: Aspirin for prevention of preeclampsia
  publication-title: Drugs
– volume: 128
  start-page: 261
  year: 2016
  end-page: 269
  article-title: Soluble fms‐Like Tyrosine Kinase‐1‐to‐Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia
  publication-title: Obstet Gynecol
– volume: 13
  year: 2013
  article-title: Vasoactive agents for the prediction of early‐ and late‐onset preeclampsia in a high‐risk cohort
  publication-title: BMC Pregnancy Childbirth
– volume: 31
  start-page: 3
  year: 2011
  end-page: 6
  article-title: A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment
  publication-title: Prenat Diagn
– volume: 210
  start-page: e1
  issue: 66
  year: 2014
  end-page: 7
  article-title: Placental pathology suggesting that preeclampsia is more than one disease
  publication-title: Am J Obstet Gynecol
– volume: 355
  start-page: 992
  year: 2006
  end-page: 1005
  article-title: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
  publication-title: N Engl J Med
– volume: 217
  start-page: 685.e1
  year: 2017
  end-page: 5
  article-title: Aspirin for Evidence‐Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
  publication-title: Am J Obstet Gynecol
– volume: 218
  start-page: 287
  year: 2018
  end-page: 293.e1
  article-title: Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
  publication-title: Am J Obstet Gynecol
– volume: 43
  start-page: 768
  year: 2010
  end-page: 770
  article-title: Multicenter evaluation of the first automated Elecsys sFlt‐1 and PlGF assays in normal pregnancies and preeclampsia
  publication-title: Clin Biochem
– volume: 48
  start-page: 765
  year: 2016
  end-page: 771
  article-title: sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK
  publication-title: Ultrasound Obstet Gynecol
– volume: 71
  start-page: 306
  year: 2018
  end-page: 316
  article-title: Meta‐analysis and systematic review to assess the role of soluble FMS‐like tyrosine kinase‐1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study
  publication-title: Hypertension
– volume: 33
  start-page: 422
  year: 2010
  end-page: 427
  article-title: Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt‐1 and PlGF levels in women with preeclampsia
  publication-title: Hypertens Res
– volume: 376
  start-page: 631
  year: 2010
  end-page: 644
  article-title: Pre‐eclampsia
  publication-title: Lancet
– volume: 217
  start-page: 585.e1
  year: 2017
  end-page: 5
  article-title: Aspirin for Evidence‐Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history
  publication-title: Am J Obstet Gynecol
– volume: 116
  start-page: 402
  year: 2010
  end-page: 414
  article-title: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta‐analysis
  publication-title: Obstet Gynecol
– volume: 113
  start-page: 1299
  year: 2009
  end-page: 1306
  article-title: Hypertensive disorders and severe obstetric morbidity in the United States
  publication-title: Obstet Gynecol
– volume: 332
  start-page: 463
  year: 2006
  end-page: 468
  article-title: Management of pre‐eclampsia
  publication-title: BMJ
– volume: 218
  start-page: e1
  issue: 612
  year: 2018
  end-page: 6
  article-title: Aspirin for Evidence‐Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
  publication-title: Am J Obstet Gynecol
– volume: 33
  start-page: 130
  year: 2009
  end-page: 137
  article-title: The global impact of pre‐eclampsia and eclampsia
  publication-title: Semin Perinatol
– volume: 2018
  year: 2018
  article-title: Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction
  publication-title: ScientificWorldJournal
– volume: 49
  start-page: 188
  year: 2017
  end-page: 193
  article-title: Validation of a first‐trimester screening model for pre‐eclampsia in an unselected population
  publication-title: Ultrasound Obstet Gynecol
– volume: 53
  start-page: 367
  year: 2019
  end-page: 375
  article-title: Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting
  publication-title: Ultrasound Obstet Gynecol
– ident: e_1_2_3_15_1
  doi: 10.1056/NEJMoa055352
– ident: e_1_2_3_8_1
  doi: 10.1136/bmj.332.7539.463
– ident: e_1_2_3_36_1
  doi: 10.1002/uog.19112
– volume: 122
  start-page: 1122
  year: 2013
  ident: e_1_2_3_5_1
  article-title: Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy
  publication-title: Obstet Gynecol
– ident: e_1_2_3_16_1
  doi: 10.1016/j.ajog.2008.06.069
– ident: e_1_2_3_62_1
  doi: 10.1002/uog.19099
– ident: e_1_2_3_42_1
  doi: 10.1016/j.ajog.2017.11.561
– ident: e_1_2_3_27_1
  doi: 10.1097/AOG.0000000000001525
– ident: e_1_2_3_30_1
  doi: 10.1002/uog.19019
– ident: e_1_2_3_57_1
– ident: e_1_2_3_10_1
  doi: 10.1155/2018/6268276
– ident: e_1_2_3_66_1
  doi: 10.1186/1471-2393-14-324
– volume: 7
  start-page: 467
  year: 2011
  ident: e_1_2_3_4_1
  article-title: Pre‐eclampsia: pathophysiology, diagnosis, and management
  publication-title: Vasc Health Risk Manag
– ident: e_1_2_3_44_1
  doi: 10.1097/AOG.0b013e3181e9322a
– ident: e_1_2_3_46_1
  doi: 10.1002/uog.19076
– ident: e_1_2_3_20_1
  doi: 10.1056/NEJMoa1414838
– ident: e_1_2_3_45_1
  doi: 10.1016/j.ajog.2016.10.016
– ident: e_1_2_3_54_1
  doi: 10.1161/HYPERTENSIONAHA.113.01787
– ident: e_1_2_3_22_1
  doi: 10.1002/uog.18816
– ident: e_1_2_3_12_1
  doi: 10.18203/2320-1770.ijrcog20182333
– ident: e_1_2_3_40_1
  doi: 10.1016/j.ajog.2017.08.110
– ident: e_1_2_3_14_1
  doi: 10.1056/NEJMoa031884
– ident: e_1_2_3_32_1
  doi: 10.1016/j.ajog.2015.08.034
– ident: e_1_2_3_60_1
  doi: 10.3390/ijms160819009
– ident: e_1_2_3_63_1
  doi: 10.1161/HYPERTENSIONAHA.116.08620
– ident: e_1_2_3_34_1
  doi: 10.1111/1471-0528.13334
– ident: e_1_2_3_61_1
  doi: 10.1016/j.preghy.2018.06.017
– ident: e_1_2_3_50_1
  doi: 10.1111/1471-0528.15042
– ident: e_1_2_3_65_1
  doi: 10.1002/uog.17307
– ident: e_1_2_3_13_1
  doi: 10.1097/AOG.0b013e3181a45b25
– ident: e_1_2_3_7_1
  doi: 10.1016/j.preghy.2014.02.001
– ident: e_1_2_3_37_1
  doi: 10.1002/pd.4519
– ident: e_1_2_3_49_1
  doi: 10.1161/HYPERTENSIONAHA.117.10182
– ident: e_1_2_3_2_1
  doi: 10.1111/1471-0528.12629
– ident: e_1_2_3_31_1
  doi: 10.1016/j.ajog.2015.02.018
– ident: e_1_2_3_39_1
  doi: 10.1007/s40265-017-0823-0
– ident: e_1_2_3_48_1
  doi: 10.1002/pd.2685
– ident: e_1_2_3_33_1
  doi: 10.1002/uog.19039
– ident: e_1_2_3_43_1
  doi: 10.1016/j.ajog.2016.09.076
– ident: e_1_2_3_64_1
  doi: 10.1002/uog.19111
– ident: e_1_2_3_24_1
  doi: 10.1056/NEJMoa1704559
– ident: e_1_2_3_25_1
  doi: 10.1016/j.ajog.2018.11.1087
– ident: e_1_2_3_19_1
  doi: 10.1016/j.ajog.2011.07.037
– ident: e_1_2_3_21_1
  doi: 10.1186/1471-2393-13-110
– ident: e_1_2_3_35_1
  doi: 10.1161/HYPERTENSIONAHA.108.127977
– volume: 218
  start-page: e1
  issue: 612
  year: 2018
  ident: e_1_2_3_47_1
  article-title: Aspirin for Evidence‐Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
  publication-title: Am J Obstet Gynecol
– ident: e_1_2_3_3_1
  doi: 10.1053/j.semperi.2009.02.010
– ident: e_1_2_3_53_1
  doi: 10.1016/j.ajog.2009.07.025
– ident: e_1_2_3_51_1
  doi: 10.1038/hr.2010.15
– ident: e_1_2_3_18_1
  doi: 10.1067/mob.2003.111
– volume: 29
  start-page: 551
  year: 2012
  ident: e_1_2_3_23_1
  article-title: Early administration of low‐dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta‐analysis
  publication-title: Am J Perinatol
– ident: e_1_2_3_17_1
  doi: 10.1016/j.ajog.2004.11.038
– ident: e_1_2_3_58_1
  doi: 10.1186/s12913-018-3406-1
– ident: e_1_2_3_6_1
  doi: 10.1161/HYPERTENSIONAHA.117.10803
– ident: e_1_2_3_59_1
  doi: 10.1002/uog.15997
– ident: e_1_2_3_55_1
  doi: 10.1002/uog.19178
– ident: e_1_2_3_9_1
  doi: 10.1016/S0140-6736(10)60279-6
– ident: e_1_2_3_41_1
  doi: 10.1016/j.ajog.2017.07.038
– ident: e_1_2_3_29_1
  doi: 10.3390/ijms160817952
– ident: e_1_2_3_38_1
  doi: 10.1002/uog.15982
– ident: e_1_2_3_28_1
– ident: e_1_2_3_56_1
  doi: 10.1161/HYPERTENSIONAHA.119.12760
– volume: 210
  start-page: e1
  issue: 66
  year: 2014
  ident: e_1_2_3_11_1
  article-title: Placental pathology suggesting that preeclampsia is more than one disease
  publication-title: Am J Obstet Gynecol
– ident: e_1_2_3_26_1
  doi: 10.1016/j.ajog.2015.11.016
– ident: e_1_2_3_52_1
  doi: 10.1016/j.clinbiochem.2010.02.010
RestrictionsOnAccess open access
SSID ssj0006436
Score 2.4442084
SourceID liege
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5
SubjectTerms Eclampsia
Female
General Medicine
Health risk assessment
Human health sciences
Humans
Médecine de la reproduction (Gynécologie, andrologie, obstétrique)
Obstetrics and Gynecology
Pre-Eclampsia
Pre-Eclampsia/diagnosis
Predictive Value of Tests
Preeclampsia
Pregnancy
Pregnancy complications
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Prenatal Diagnosis
Radiological and Ultrasound Technology
Radiology, Nuclear Medicine and Imaging
Reproductive Medicine
Reproductive medicine (gynecology, andrology, obstetrics)
Risk Assessment
Sciences de la santé humaine
Ultrasonic imaging
Ultrasonography, Prenatal
Title From first‐trimester screening to risk stratification of evolving pre‐eclampsia in second and third trimesters of pregnancy: comprehensive approach
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fuog.21869
https://www.ncbi.nlm.nih.gov/pubmed/31503374
https://www.proquest.com/docview/2331707615
https://www.proquest.com/docview/2288013375
http://orbi.ulg.ac.be/handle/2268/312134
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1469-0705
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1469-0705
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0006436
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkRCX8qZbSmUQhx7INrGTeAMnhFgqpAJCrNQDkuU49jZim6zyQIITP6G3_j9-CTPOoyoqEuKQKFLG1tgZj-eVz4Q88w0mi4LEi7I09ED7JV5qhfCE1bEOVRYlGh3Fo_fx4SJ8dxwdb5CXw78wHT7EGHDDleH0NS5wldYHF6ChbbmcugOVQP8GPHIp2k8X0FGw07o8JVjonogTNqAK-exgbHlpL7q-wiz1VYbmZbvVbTzzW-TLwHJXb_J12jbpVP_4A83xP8d0m2z1Bil91UnQHbJhirvkxlGfcr9HzudVeUptDlbir59nDZ4GgNgKFNQNuMCw8dGmpFigTjsEXtsHAWlpqQHdhwELuq4MNDYaxG9d54rmBa3RE8-ogqs5ySu4D13X2BRaLBEL5PsLilXvlTnpKu3pAIJ-nyzmbz6_PvT60xw8HXKWeMpXwg9mSoCDJ6xhXOs4MSbMmGUa3LhEW-XrEAsKwxkzehbEQmSp0JzpJLaKPyCbRVmYbUJFYuNI2IBlKcLjYKoSgeE1AttglGxC9ofvKnUPdY4nbqxkB9LMJEy0dBM9IU9H0nWH73EV0XMnHLKs0lx-YxIxud1zu1pKpWVqJJixM8kdQN6E7A4yJHuNUEvGwVLDoBFw92R8DWsZEzSqMGULNAwGEHAugOZhJ3sjUzzAhLOAzvedBP2dW7n48NY97Pw76SNyk2EgwcWWdslmU7XmMVhbTbpHrrHw455bXL8B-iIpzw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKwEXRHkulGIQhx5ImzjeeF1xqaouC3QLh67Um-U49jbSkqyyWSRu_ARu_D9-SWecB6rUShwSWcrYcjKe8bzymZB3ocVkUSSDYZbyALSfDFInRCCcSQzX2VAadBSnZ8lkxj9fDC82yIfuX5gGH6IPuKFkeH2NAo4B6YN_qKHrcr7vT1S6Q7Z4wkJc04x_6_Uw7LU-Uwk2eiASyTpcoZAd9F2v7UZbC8xT32RqXrdc_dYzfkgetDYjPWqYvE02bPGI3J22WfHH5M-4Kr9Tl4Mh9_fX7xoB-xH-gIJGAC8V9iZalxRryGkDkuvaOB0tHbWgnjCmQJeVhc7WwApZrnJN84Ku0FnOqIarvswruHdDr7Ar9JgjXMfPQ4qF6ZW9bIrhaYdT_oTMxifnx5OgPXAhMDxmMtChFmE00gJ8MOEsi41JpLU8Y44Z8LSkcTo0HGv--IhZM4oSIbJUmJgZmTgdPyWbRVnY54QK6ZKhcBHLUkSwwWwiYrcbxJ7BQNaA7HUfXpkWjRwPxVioBkeZKeCR8jwakLc96bKB4LiJ6L3nniqrNFc_mELYbN9eL-ZKG5VaBZbmSMUew25Adjomq1ZoV4rFYExhXAdm96Z_DOKGORRd2HINNAxeAPx6ATTPmsXRTyqOMCcsYPA9v1pun62aff3oGy_-n_Q1uTc5n56q009nX16S-wz9fh8K2iGbdbW2r8A4qtNdLwNXz_EMSw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKK1VcKG-2LWAQhx7INnGy8RpOCFjKowUhVuqhkuU49jZim6yyCRKc-Anc-H_9JZ1xHlVRkRCHRJEyjuxkPP7mkc-EPPENJosC4Y3SJPLA-gkvsZx73OpYRyodCY2O4v5BvDeN3h2ODlfI8-5fmIYfog-44cxw9hon-CK1u-ekoXUxG7oNla6QtSgG7woR0edz7ihYal2iEiC6x2PBOlohn-32TS8sRmtzTFNfhjQvAle38kw2yFHX56bg5OuwrpKh_vEHneN_Duo6udYiUvqiUaEbZMXkN8n6fptzv0V-T8rihNoMYOLpz18VbgeA5AoU7A34wLDy0aqgWKFOGwpe20YBaWGpAeOHEQu6KA00Nhr0b7HMFM1yukRXPKUKjuo4K-HcPXqJTaHFDMlAvj-jWPZemuOm1J52LOi3yXTy-svLPa_dzsHTUciEp3zF_WCsOHh43BoWah0LY6KUWabBjxPaKl9HWFEYjZnR4yDmPE24DpkWsVXhHbKaF7m5RygXNh5xG7A0QX4czFUiM7xGZhsMkw3ITvddpW65znHLjblsWJqZhBct3YsekMe96KIh-LhM6KlTDlmUSSa_MYmk3O66ns-k0jIxEnDsWIaOIW9Atjsdkq1JWEoWAlTDqBH07lF_GyYzZmhUbooaZBgMIAhDDjJ3G93rOxUGmHHm8PAdp0F_762cfnzjLjb_XfQhWf_0aiI_vD14v0WuMgwquDjTNlmtytrcB-RVJQ_cDDsDzfYrww
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+first%E2%80%90trimester+screening+to+risk+stratification+of+evolving+pre%E2%80%90eclampsia+in+second+and+third+trimesters+of+pregnancy%3A+comprehensive+approach&rft.jtitle=Ultrasound+in+obstetrics+%26+gynecology&rft.au=Poon%2C+L.+C&rft.au=Galindo%2C+A&rft.au=Surbek%2C+D&rft.au=Chantraine%2C+F&rft.date=2020-01-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0960-7692&rft.eissn=1469-0705&rft.volume=55&rft.issue=1&rft.spage=5&rft.epage=12&rft_id=info:doi/10.1002%2Fuog.21869&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-7692&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-7692&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-7692&client=summon